BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2462439)

  • 1. Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinoma.
    Buxton EJ; Meanwell CA; Mould JJ; Latief T; Chetiyawardana AD; Spooner D; Tobias JS; Sokal M; Alcock C; Hilton C
    Acta Oncol; 1988; 27(5):545-9. PubMed ID: 2462439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ifosfamide in cervical cancer.
    Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer.
    Buxton EJ; Meanwell CA; Hilton C; Mould JJ; Spooner D; Chetiyawardana A; Latief T; Paterson M; Redman CW; Luesley DM
    J Natl Cancer Inst; 1989 Mar; 81(5):359-61. PubMed ID: 2464699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II studies of ifosfamide alone and in combination in cancer of the cervix.
    Blackledge G; Buxton EJ; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S12-6. PubMed ID: 1693314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in recurrent and advanced cervical cancer.
    Kumar L; Bhargava VL
    Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
    Singhal RM; Jindel R; Gupta AK
    Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single agent versus combination chemotherapy in recurrent cervical cancer.
    Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V
    J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.
    Ramm K; Vergote IB; Kaern J; Tropé CG
    Gynecol Oncol; 1992 Aug; 46(2):203-7. PubMed ID: 1379961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma.
    Hempling RE; Eltabbakh GH; Piver MS; Recio FO; O'Neill CP
    Am J Clin Oncol; 1997 Jun; 20(3):315-8. PubMed ID: 9167762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
    Tay SK; Lai FM; Soh LT; Ho TH; Ang PT; Au E
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):263-6. PubMed ID: 1280100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.
    Herod J; Burton A; Buxton J; Tobias J; Luesley D; Jordan S; Dunn J; Poole CJ
    Ann Oncol; 2000 Sep; 11(9):1175-81. PubMed ID: 11061615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin, ifosfamide, and cisplatin (BIP) in patients with recurrent and advanced cervical cancer.
    Manetta A
    Gynecol Oncol; 1991 Jul; 42(1):104-5. PubMed ID: 1717353
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer.
    Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix.
    Choi CH; Kim TJ; Lee SJ; Lee JW; Kim BG; Lee JH; Bae DS
    Int J Gynecol Cancer; 2006; 16(3):1157-64. PubMed ID: 16803500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer.
    Hirabayashi K; Okada E
    Cancer; 1993 May; 71(9):2769-75. PubMed ID: 7682148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
    Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
    Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.
    Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG
    Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.